MoneyWorks4Me

Strides Pharma Science informs about press release

06 Sep 2024 Evaluate
Strides Pharma Science has informed that it attached Press Release issued by the Company titled: ‘Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..